Allergic rhinitis and asthma symptoms in a real-life study of MP-AzeFlu to treat multimorbid allergic rhinitis and asthma
Abstract Background Asthma affects up to nearly 40% of patients with allergic rhinitis (AR). Poor control of AR symptoms is associated with poor asthma control. The goal of this study was to evaluate the effect of AR treatment with MP-AzeFlu on symptoms of AR as well as symptoms of asthma. Methods T...
Main Authors: | David Price, Ludger Klimek, Gabriella Gálffy, Melanie Emmeluth, Arkady Koltun, Ferdinand Kopietz, Duc Tung Nguyen, Ranny van Weissenbruch, Wolfgang Pohl, Hans-Christian Kuhl, Glenis Scadding, Joaquim Mullol |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-08-01
|
Series: | Clinical and Molecular Allergy |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12948-020-00130-9 |
Similar Items
-
MP-AzeFlu Improves the Quality-of-Life of Patients with Allergic Rhinitis
by: van Weissenbruch R, et al.
Published: (2020-12-01) -
Superior effect of MP-AzeFlu than azelastine or fluticasone propionate alone on reducing inflammatory markers
by: Jordi Roca-Ferrer, et al.
Published: (2018-12-01) -
The complex pathophysiology of allergic rhinitis: scientific rationale for the development of an alternative treatment option
by: Leif Bjermer, et al.
Published: (2019-04-01) -
Rapid onset of action and reduced nasal hyperreactivity: new targets in allergic rhinitis management
by: C. Bachert, et al.
Published: (2018-06-01) -
A review of the clinical efficacy and safety of MP-AzeFlu, a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate, in clinical studies conducted during different allergy seasons in the US
by: Prenner BM
Published: (2016-07-01)